Anika Therapeutics
ANIK
ANIK
116 hedge funds and large institutions have $242M invested in Anika Therapeutics in 2023 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 29 increasing their positions, 45 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
36% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 45
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
67% less call options, than puts
Call options by funds: $17K | Put options by funds: $52K
Holders
116
Holding in Top 10
1
Calls
$17K
Puts
$52K
Top Buyers
| 1 | +$8.27M | |
| 2 | +$7.65M | |
| 3 | +$6.73M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4.06M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.59M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$8.5M | |
| 3 | -$3.59M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$2.82M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$2.25M |